Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
He has been paid handsomely considering what he has delivered . He doesn't have a science background , he was the wrong choice for the job. As for options they should be performance related , hence they should have lapsed with him receiving nothing imo.
Gixer
he wouldn’t buy the shares, he would just get the delta between strike and exercise price. The tax position is unknown as he may get entrepreneur tax rates.
Agreed 2p isn’t exciting, 5p would be more life changing.
- would make my holding worth £2.5 M gross
W$$$$$
minus initial purchase price.
I seem to be missing 7m somewhere as he appears to have 50m
So selling the company @ 2p, as everhopeful suggests, is not that beneficial to him. IMO
But who knows what the SP will be by April 2022.
Gixer
so in essence he gets 350£k fo every penny rise above where we are now - we don’t know what the other criteria are in order to exercise. Subject to tax 3 to 5p would net him a mill.
W$
At this moment, and please someone correct me if I am wrong, he has 10m (from memory) that are exercisable at a price of 0.55p
25m available to him from April 2022 @0.3p
and
8m at a price of 2.8p (i think these are due to run out soon)
Gixer
his options are where the money is for him
W$
everhopeful, If as you say "he is just a taker" then he would be taking very little if he sold just now for 2p.
From memory he has 10m shares and half of them (5m) are for his kids. Be lucky if that got them through Uni.
thanks for the research Gixer.
Re To and what price , I said that IF would take 2p because I do not think his heart is in this business he is just a taker , hope that doesn't happen . Someone mentioned 22p , bring it on . 9 years ago I was saying 33p. been under water ever since.
PS still not got anyone to buy FF despite giving away pills and them approving of the results , why is this so hard ?
Hi Gixer,
Thanks for your thoughtful response. I agree that the news of China will fly the PXS, which was shown with the recent China news. My doubt is that it will be picked by By-Health or somebody else before it will hit the prospective share price. It is always to have a nice and constructive discussion from either side of the fence. However it is not nice to attack people and pick up spelling correction as some people do here (not you gixer).
Steve, last year was £222k so I think £500k might be pushing it a bit even although they did say "Strong start to the 2020/21 financial year for this business, with first quarter revenues substantially ahead of the comparative quarter in 2019/20." WRT Dsm revenue.
Not long till we find out
colbaltblue, in reply to your point 1.
I agree that there will be a slight delay in payment between By-health ordering Fruitflow from DSM and the cash arriving in PXS bank account but that would depend on the payment term if any DSM give By-Health. By-Health will have to order Fruitflow before any products hit the shelves.
"If a successful blue cap health claim is achieved for Fruitflow in China it would currently be expected to result in some significant recurring orders for Fruitflow, at a multiple of current total sales values."
I assume there will be no change to the AA for By-Health purchases so would still give PXS "a multiple of current total sales values" all be it not in a one off payment.
2. For sure there will be holder selling into any rise, especially ones who got in at the lows. Volume is low but you only need to look back a few weeks when FF+ in China was announced to see what an increase in volume can do to the SP.
All IMO though.
Steve. In order to progress that patent to a commercial health claim, an awful lot more spending on clinical testing would be necessary. Very frustrating, but it's pone of the many things I refer to when I say that cash generation could unlock so much more. ATB
The priority for me is to see the company become cash generative, which would end the perennial constraint on ambition. When that happens, many things become possible, things that posters here accuse the company of not doing. I believe that the retail arm could have real potential.
DD77. Rare that a poster regards myself and Colb in the same manner !!
Yeah, errm, luv you too :-)
gixer, I'm always happy to engage with a poster who never makes this a personal issue. I regard Fruitflow as a superb product and I've been using it for many years and will continue to use it. I have always regretted the fact that it is still not as well known as it should be and that it has not been driven harder into the professional and public arena.
To respond to your points:
1) As far as I understand the announcement in 2019, By-health will have a range of Fruitflow related products available via various outlets post blue cap. We don't know much more but the indication is that trials are progressing satisfactorily. I'm assuming that the supply of FF will be acquired via DSM and therefore the share to Provexis is unknown outside of the people party to the arrangements. Therefore, the eventual benefit to the bottom line of PXS will come via an agreed distribution from DSM. This will only occur after prospective sales in China, hence the potential delay IMO.
2) More of a gut feeling but I've seen the collective sigh of relief from other "lifers" in other shares when, after many years, a SP actually begins to rise and people can recover some cash. In addition, where will the NEW buyers come from? Volumes tell me that there is little appetite for this share at the moment and AIM has changed enormously in the last 5 years. It is now very much a wild west casino for short-termers looking for a quick buck
DP64, I know its always good to have an exit strategy but with PXS I don't, not yet anyway, but I doubt very much I would be selling in "one go".
I have a few shares but far from a significant holder unfortunately.
DP64, DD77 and alfista. Thanks.
Hi Gixer,
Just to say you another thanks for your wonderful research. Just matter of interest what price will you exit as you are one of the significant share holder. Are you planning to exit phase by phase or just at one go?
Cob,
I am here before 2009, so longer than you. You probably very busy in checking spelling and attacking people to get an attention. Keep it up.
How ironic that alfista calls out people for conduct, given they are the chief name caller when anyone dares to question the company. He lost all credibility a long time ago.
Gixer - you are a gem keeping us informed on here, it might appear a thankless task but it provides us with a semblance of what's going on. Why PXS are not doing is, is beyond belief.
As for future valuation, it's all speculation. Noone knows how it will take off in China, if/when Blue Cap is approved. Double digits is pipedream in my opinion but not impossible. I think the SP could double next year and perhaps reach 3p but i'd expect it to be taken over in the short-medium term if it achieves Blue Cap.
I'm pleasantly surprised and encouraged that the SP is holding up, in spite of the imminent raise
Cobalt - bang on the money (pun intended!) LTH if it hits 2p I'll be at the exit door. Have got my average down to 1.79p, so it might even be before that. PXS was one of my earliest 'investments' and I recall the coca cola hype. The fact I'm still here shows how much it was a classic erroneous novice investor play. One day Rodders.... as it went back then
Agree with that on both points Gixer. I see it as a simple matter of Colb projecting his own view as that of the majority. Since no other holder has followed the same path as he did, buying at a peak, selling most of his holding at a low, leaving an unreachable average, it's more than clear that he is isolated amongst the main view. Another case of higher education creating delusions of grandeur.
There are a number of future outcomes possible, including a bid for the entire company. I don't think anyone other than the BoD have any specific knowledge of what the future may hold, but, mainly thanks to you, we can see positive developments. for me, that'll do for now. I would, however, like the sp to reach a point where the moaner leaves us. Obs :-)
CB
although there are more shares, we have a lot more health claims cf 2009.
I think 5p would be a good result, but I’m expecting nearer 3p. Given the very large stock options the board have, this range would make them very comfortable indeed.
However if by some good fortune we go mainstream - i.e. FF adverts in middle of Corrie, then 22p would not be unreasonable for a takeover scenario and IF would get on the rich list ? lol
W$
Hi colbaltblue, not saying you are wrong. Or right for that matter but it would be interesting to get your view on 2 of the points you make.
1. "The time to start thinking about a couple of pence is when the company makes a profit and that won't happen for years IMO."
Years is quite an open statement so not sure how you come to this conclusion.
Me. I think we will be in profit soon after By-Health gets blue Cap.
2. "there is a huge head of steam for many lifers to exit this disappointing share as soon as anything in excess of 2p is reached."
Not sure there is any evidence of long term holders saying they would sell at 2p. Many LTH could already be in profit if they had averaged down over the years but i have no idea when they will sell.
DP64, the fictitious spike of 2009/2010, I can't remember exactly when, was a brief blip which nobody managed to sell on. The spike was caused by a rumour of a deal with Coca-cola. In addition there were far less shares in issue at that time. if you want to think about a "spike" you need to revisit the time when the then CEO bailed out at approx 7p to finish his home improvements!
Any dreamer who thinks this share will get into double figures anytime soon is delusional IMO. The time to start thinking about a couple of pence is when the company makes a profit and that won't happen for years IMO. I remind you that the vast part of the current income is used up in the form of remuneration to the BOD. I know you're only a recent visitor here and have only been a member of LSE for 5 minutes displaying very little knowledge in general, but I assure you, IMO, there is a huge head of steam for many lifers to exit this disappointing share as soon as anything in excess of 2p is reached. It's almost comical that you, a newby to PXS, lecture me as I have held this share since 2009. Please do some research for a change. Read back through the accounts and check the charts but don't do it late at night. You'll have nightmares! It's not a pretty history.
Don't think this product has been posted before but no idea if its new.
GNC SCIENTIFIC NUTRITION BRAIN HEALTH FORMULA
https://www.gnc.ie/gnc-scientific-nutrition-brain-health-formula-90
GNC Holdings, Inc. seem to have been in a bit of trouble recently but were sold to Harbin Pharmaceutical Group.
In June 2020, the company filed for Chapter 11 bankruptcy protection and indicated plans to close at least 800 stores.[16] Effective on June 30, 2020, the stock was delisted from the New York Stock Exchange and shifted to the OTC Pink market.[17] In September 2020, the bankruptcy court in Delaware approved the sale of GNC for $770 million to Harbin Pharmaceutical Group
https://en.wikipedia.org/wiki/GNC_(store)
Harbin Pharmaceutical Group Co is a Chinese -based company
https://www.post-gazette.com/business/healthcare-business/2020/09/17/approved-bankruptcy-sale-GNC-770-million-harbin-Pharmaceutical-stores-vitamin/stories/202009170164
What does that mean? Probably SFA but I found it interesting that the Fruitflow Trade Mark licence agreement popped up in the Chapter 11
https://cases.primeclerk.com/GNC/Home-DownloadPDF?id1=MTYwMzU4Mw==&id2=0
Hi Gixer,
Fully agreed with your thoughts about what is mentioned in the report. I have a strong believe that we will be bought long before the full potential of fruitflow is exploited. A lots of share holder will agree below 10p a share. I am not sure what SL is thinking about his significant interest in PXS. My personal view is that we should hold it till the full potential of fruitflow is exploited as we have been holding so long and missed the last 22p spike. Those people who are too busy to check the spelling probably do not have any clue about whatever mentioned in the last PXS report.